Quick Answer
This glossary defines the terms that recur across peptide research, sourcing, and regulation, from amino acid and lyophilised to net peptide content and Category 2 compounding. Several of these terms describe how a product is sold or tested rather than whether it is approved for human use, a distinction this glossary keeps explicit throughout.
Terms are grouped by theme rather than alphabetically, so related concepts sit together. Where a term has its own dedicated guide, the entry gives the short definition and links out instead of repeating the detail.
Peptide Basics
A peptide is a short chain of amino acids linked by peptide bonds. The line between a peptide and a protein is a question of size, and for regulatory purposes the United States draws it precisely: in a rule codified in the Federal Register (83 FR 63817, December 2018), the FDA defines a peptide as any alpha amino acid polymer of 40 or fewer amino acids, with anything larger treated as a protein. The IUPAC-IUB nomenclature convention uses a looser range of 2 to 50 residues. By the FDA standard, the compounds most often discussed in this space sit firmly in peptide territory: BPC-157 is 15 amino acids, MOTS-c is 16, and thymosin beta-4 is 43, while insulin, first administered clinically in 1922, is a 51-amino-acid two-chain hormone that falls on the protein side of the cutoff.
| Term | Meaning |
|---|---|
| Peptide | A chain of amino acids; the FDA defines it as 40 or fewer amino acids in length. |
| Amino acid | The individual building block of a peptide or protein. |
| Residue | A single amino acid unit as it sits within a chain. |
| Sequence | The specific order of amino acids that defines a given peptide. |
| Analogue | A modified version of a natural peptide, altered to change stability or activity. |
| Agonist | A molecule that binds and activates a receptor. |
| GLP-1 receptor agonist | A compound that activates the GLP-1 receptor; the class semaglutide and tirzepatide belong to. |
| Secretagogue | A substance that prompts the body to secrete something, such as a growth-hormone secretagogue. |
| GHRH / GHRP | Growth-hormone-releasing hormone and growth-hormone-releasing peptide; two classes that act on the pituitary. |
| Half-life | The time it takes for a compound’s concentration in the body to fall by half. |
| Bioavailability | The proportion of an administered compound that actually reaches circulation. |
The bottom line: a peptide is an amino acid chain, and in the United States the regulatory dividing line from a protein is a hard 40-amino-acid cutoff.
Forms, Handling and Diluents
Research peptides are almost always supplied as a lyophilised (freeze-dried) powder that has to be dissolved before use. The terms below cover the physical form, the units, and the diluents involved. PeptideGuider does not publish reconstitution or injection protocols; these entries define the vocabulary only.
| Term | Meaning |
|---|---|
| Lyophilised | Freeze-dried; the powdered state in which most research peptides ship. |
| Reconstitution | Dissolving a lyophilised powder in a sterile diluent to produce a solution. |
| Bacteriostatic water | Sterile water with 0.9% benzyl alcohol, the standard multi-use diluent. See our full explainer on bacteriostatic water. |
| Sterile water for injection | Preservative-free water; single-use because it has no antimicrobial agent. |
| Benzyl alcohol | The preservative that makes bacteriostatic water reusable and drives its safety warnings. |
| Subcutaneous / intramuscular | Administration into the layer under the skin, or into muscle, respectively. |
| mcg vs mg | Microgram and milligram; 1 mg equals 1,000 mcg, a frequent source of error. |
| Multiple-dose vial | A container designed for repeated withdrawals, which requires a preservative. |
| Aliquot | A measured portion divided off from a larger quantity, often stored separately. |
The bottom line: peptides ship lyophilised and are dissolved in a diluent, and the choice between a preservative-containing and a preservative-free diluent decides whether a vial is single or multiple use.
Purity, Testing and Quality
The most consequential terms in research-peptide sourcing are the ones about what is actually in the vial. Two of them get confused constantly: chromatographic purity (how clean the peptide is) and net peptide content (how much peptide there is by weight). They are different measurements, and a product can score high on one and low on the other.
A large part of that gap comes down to counterions, a term most consumer glossaries skip entirely. Every synthetic peptide made by standard Fmoc solid-phase synthesis carries charged counterion molecules that pair with basic sites on the chain. The default is trifluoroacetate (TFA), a byproduct of the synthesis and purification steps, which weighs 114 daltons per counterion; an acetate counterion weighs only 59 daltons. Because TFA is heavier, a TFA-salt vial contains less actual peptide by weight than an acetate-salt vial of the same labelled mass, and for a peptide with several basic sites the counterion can account for 15 to 25% of the total powder weight. How that translates into measured net peptide content, and how a lab reports it, is covered in our walkthrough of what a certificate of analysis proves.
| Term | Meaning |
|---|---|
| Certificate of Analysis (COA) | The lab document reporting a batch’s identity, chromatographic purity, and contaminant testing. |
| HPLC | High-performance liquid chromatography, the standard purity test. See how the testing methods compare. |
| Mass spectrometry | A method that confirms a peptide’s molecular weight and identity. |
| Chromatographic purity | The percentage of the sample that is the target peptide rather than impurities. |
| Net peptide content | The actual mass of peptide in a vial after counterions, water, and salts are removed. |
| Counterion / salt form | The charged molecule paired with the peptide; TFA (114 Da) and acetate (59 Da) are the common forms. |
| Endotoxin | A bacterial contaminant tested for separately from purity; reported on a thorough COA. |
| Nonpyrogenic | Free of fever-inducing substances such as endotoxin. |
| USP | United States Pharmacopeia, which sets official quality standards and monographs. |
| cGMP | Current Good Manufacturing Practice, the FDA quality-system standard for manufacturing. |
| Third-party testing | Independent-lab testing rather than a seller’s own; the leading trust signal in vendor vetting. |
| Lot / batch number | The identifier tying a vial to a specific production run and its test data. |
| Pyrogen | A fever-inducing substance; “nonpyrogenic” means a preparation is free of them. |
The bottom line: purity and net peptide content measure different things, and the counterion salt form is the hidden variable that drives much of the difference.
Regulation and Legality
The regulatory vocabulary is where the most consequential misunderstandings happen, because phrases like “research use only” read like permissions when they are really just sales-channel labels. The entries below are short by design; each topic has a dedicated guide that covers it in full.
| Term | Meaning |
|---|---|
| Research use only (RUO) | A sales-channel designation; it carries no approval for human use. Unpacked in the US legal framework. |
| FDA Category 1 vs Category 2 | The compounding bulk-substance categories. See what the categories mean. |
| 503A / 503B | The two compounding pathways: patient-specific pharmacies (503A) and outsourcing facilities (503B). |
| Compounding | Preparing a tailored medication outside standard mass manufacturing. |
| Bulk drug substance | An active ingredient a compounder may use; the category lists govern which peptides qualify. |
| NDA | New Drug Application, the FDA approval route a prescription drug must clear. |
| DSHEA | The 1994 supplement law; most research peptides do not qualify as dietary supplements under it. |
| MHRA / TGA | The UK and Australian medicines regulators, covered in the respective country legality guides. |
The bottom line: regulatory terms describe how a product may be sold and compounded, not whether it is approved for use, and that distinction is the one most often missed.
In this field the vocabulary is the first line of defence: knowing that “purity” and “net content” are different numbers, or that “research use only” is a sales label, is often what separates an informed reader from a misled one.
Medical disclaimer. This glossary is for informational purposes only and is not medical advice. Definitions here describe terminology and regulatory concepts; they are not endorsements of any compound or its use. PeptideGuider does not provide dosing, reconstitution, or injection guidance. Consult a qualified healthcare professional before making any health decision.
